SC
REGN icon

SRB Corp’s Regeneron Pharmaceuticals REGN Stock Holding History

SRB Corp’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-724
Closed -$697K – 71
2024
Q1 		$697K Buy
724
+86
+13% +$81.8K 0.04% 64
2023
Q4 		$560K Buy
638
+82
+15% +$67.5K 0.03% 30
2023
Q3 		$458K Sell
556
-30
-5% -$23.6K 0.03% 60
2023
Q2 		$421K Buy
586
+100
+21% +$77.1K 0.02% 90
2023
Q1 		$399K Sell
486
-127
-21% -$95.8K 0.03% 15
2022
Q4 		$442K Sell
613
-67
-10% -$49.4K 0.03% 68
2022
Q3 		$468K Sell
680
-1,564
-70% -$984K 0.03% 14
2022
Q2 		$1.33M Buy
2,244
+82
+4% +$53.3K 0.09% 64
2022
Q1 		$1.51M Hold
2,162
– – 0.08% 40
2021
Q4 		$1.36M Sell
2,162
-384
-15% -$236K 0.07% 86
2021
Q3 		$1.54M Buy
+2,546
New +$1.58M 0.09% 79
2021
Q2 		– Sell
-3,280
Closed -$1.55M – 103
2021
Q1 		$1.55M Buy
3,280
+1,786
+120% +$870K 0.11% 57
2020
Q4 		$721K Buy
1,494
+558
+60% +$301K 0.05% 155
2020
Q3 		$524K Buy
+936
New +$568K 0.04% 130
2020
Q2 		– Sell
-1,343
Closed -$656K – 165
2020
Q1 		$656K Sell
1,343
-150
-10% -$61.9K 0.06% 12
2019
Q4 		$561K Hold
1,493
– – 0.05% 35
2019
Q3 		$414K Buy
+1,493
New +$442K 0.04% 155
2019
Q2 		– Sell
-1,683
Closed -$691K – 181
2019
Q1 		$691K Hold
1,683
– – 0.07% 97
2018
Q4 		$629K Buy
+1,683
New +$616K 0.07% 11

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SRB Corp's REGN Position: Q2 2024 in Review

SRB Corp sold out of Regeneron Pharmaceuticals (REGN) in Q2 2024, closing a stake of 724 shares — an estimated $697K sold.

SRB Corp first reported a position in REGN in Q4 2018 and held it in 19 quarters. The position peaked at $1.55M in Q1 2021. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2024.

  • SRB Corp reported no remaining Regeneron Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • SRB Corp sold 724 Regeneron Pharmaceuticals shares in Q2 2024, an estimated $697K.
  • SRB Corp first reported a position in Regeneron Pharmaceuticals in Q4 2018 and held it in 19 quarters.
  • SRB Corp's Regeneron Pharmaceuticals position peaked at $1.55M in Q1 2021.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2024.

Based on SRB Corp's 13F filing for Q2 2024, filed 14 Aug 2024.